04:28 PM EDT, 03/19/2024 (MT Newswires) -- Aquestive Therapeutics ( AQST ) disclosed plans Tuesday of an underwritten stock offering.
The company plans to grant the underwriters a 30-day option to buy up to an additional 15% shares to cover overallotments.
Aquestive plans to use the net proceeds, along with its existing cash, to advance the development and commercialization of its product pipeline, and for working capital, capital expenditures and general corporate purposes.
Shares of the company dropped nearly 13% in after-hours activity.
Price: 4.66, Change: -0.68, Percent Change: -12.73